Resultats globals: 7 registres trobats en 0.02 segons.
Articles, 7 registres trobats
Articles 7 registres trobats  
1.
11 p, 682.2 KB Mesenchymal stem cells for cardiac repair : are the actors ready for the clinical scenario? / Roura, Santiago (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gálvez-Montón, Carolina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Mirabel, Clémentine (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vives Armengol, Joaquim (Universitat Autònoma de Barcelona. Departament de Medicina) ; Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina)
For years, sufficient progress has been made in treating heart failure following myocardial infarction; however, the social and economic burdens and the costs to world health systems remain high. Moreover, treatment advances have not resolved the underlying problem of functional heart tissue loss. [...]
2017 - 10.1186/s13287-017-0695-y
Stem cell research & therapy, Vol. 8 (october 2017)  
2.
15 p, 4.5 MB Minimum Information about T Regulatory Cells : A Step toward Reproducibility and Standardization / Fuchs, Anke (Technische Universität Dresden, Germany) ; Gliwiński, Mateusz (Medical University of Gdańsk, Poland) ; Grageda, Nathali (MRC Centre for Transplantation, King's College London, Guy's Hospital) ; Spiering, Rachel (Newcastle University) ; Abbas, Abul K. (University of California, San Francisco) ; Appel, Silke (University of Bergen, Norway) ; Bacchetta, Rosa (Stanford School of Medicine, United States) ; Battaglia, Manuela (San Raffaele Hospital, Milan) ; Berglund, David (Uppsala University, Sweden) ; Blazar, Bruce (University of Minnesota, United States) ; Bluestone, Jeffrey A. (University of California, San Francisco, United States) ; Bornhäuser, Martin (Technische Universität Dresden, Germany) ; ten Brinke, Anja (University of Amsterdam) ; Brusko, Todd M. (University of Florida Diabetes Institute) ; Cools, Nathalie (University Hospital Antwerp (Bèlgica)) ; Cuturi, Maria Cristina (Université de Nantes) ; Geissler, Edward (University Hospital Regensburg, Germany) ; Giannoukakis, Nick (Carnegie Mellon University, Pittsburgh, United States) ; Gołab, Karolina (The University of Chicago, United States) ; Hafler, David A. (Yale School of Medicine, New Haven, United States) ; van Ham, S. Marieke (University of Amsterdam) ; Hester, Joanna (University of Oxford) ; Hippen, Keli (University of Minnesota, United States) ; Di Ianni, Mauro (University of Chieti-Pescara) ; Ilic, Natasa (University of Belgrade) ; Isaacs, John (National Institute for Health Research Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University) ; Issa, Fadi (University of Oxford) ; Iwaszkiewicz-Grzes, Dorota (Medical University of Gdańsk, Poland) ; Jaeckel, Elmar (Department of Gastroenterology, Hepatology, Endocrinology, Diabetology, Transplantationsforschungszentrum, Medical School of Hannover (MHH)) ; Joosten, Irma (Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboudumc, Netherlands) ; Klatzmann, David (Hôpital Pitié-Salpêtrière, Paris) ; Koenen, Hans (Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboudumc, Netherlands) ; van Kooten, Cees (Leiden University Medical Center, Netherlands) ; Korsgren, Olle (Gothenburg University, Sweden) ; Kretschmer, Karsten (University Hospital and Medical Faculty Carl Gustav Carus of TU Dresden, Germany) ; Levings, Megan (The University of British Columbia, Vancouver, Canada) ; Marek-Trzonkowska, Natalia Maria (Medical University of Gdańsk, Poland) ; Martinez-Llordella, Marc (King's College London) ; Miljkovic, Djordje (University of Belgrade) ; Mills, Kingston H. G. (Trinity College Dublin, Ireland) ; Miranda, Joana P. (Universidade de Lisboa) ; Piccirillo, Ciriaco A. (Research Institute of McGill University Health Centre, Montréal, Canada) ; Putnam, Amy L. (University of California, San Francisco) ; Ritter, Thomas (National University of Ireland) ; Roncarolo, Maria Grazia (Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, ISCBRM, Stanford School of Medicine) ; Sakaguchi, Shimon (Osaka University, Japan) ; Sánchez-Ramón, Silvia (Hospital Clínico San Carlos (Madrid)) ; Sawitzki, Birgit (Humboldt-Universität zu Berlin) ; Sofronic-Milosavljevic, Ljiljana (University of Belgrade) ; Sykes, Megan (University of California, San Francisco) ; Vives Pi, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Waldmann, Herman (University of Oxford) ; Witkowski, Piotr (The University of Chicago) ; Wood, Kathryn J. (University of Oxford) ; Gregori, Silvia (San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), San Raffaele Scientific Institute IRCCS) ; Hilkens, Catharien M. U. (Newcastle University) ; Lombardi, Giovanna (MRC Centre for Transplantation, King's College London, Guy's Hospital) ; Lord, Phillip (School of Computing, Newcastle University) ; Martinez-Caceres, Eva Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Trzonkowski, Piotr (Medical University of Gdańsk, Poland)
Cellular therapies with CD4+ T regulatory cells (Tregs) hold promise of efficacious treatment for the variety of autoimmune and allergic diseases as well as posttransplant complications. Nevertheless, current manufacturing of Tregs as a cellular medicinal product varies between different laboratories, which in turn hampers precise comparisons of the results between the studies performed. [...]
2018 - 10.3389/fimmu.2017.01844
Frontiers in immunology, Vol. 8 (january 2018)  
3.
4 p, 267.0 KB The challenge of developing human 3D organoids into medicines / Vives Armengol, Joaquim (Universitat Autònoma de Barcelona. Departament de Medicina) ; Batlle Morera, Laura (Centre de Regulació Genòmica)
The capacity of organoids to generate complex 3D structures resembling organs is revolutionizing the fields of developmental and stem cell biology. We are currently establishing the foundations for translational applications of organoids such as drug screening, personalized medicine and launching the future of cell therapy using organoids. [...]
2020 - 10.1186/s13287-020-1586-1
Stem cell research & therapy, Vol. 11 (march 2020)  
4.
9 p, 745.9 KB Long-term follow-up of renal function in patients treated with migalastat for Fabry disease / Bichet, Daniel G. (Department of Medicine, Hôpital du Sacré-Coeur, University of Montréal, Montreal, Quebec, Canada) ; Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Wallace, Eric (Department of Medicine, University of Alabama, Birmingham, AL, USA) ; Hughes, Derralynn A (Lysosomal Storage Disorders Unit, Royal Free London NHS Foundation Trust and University College London, London, UK) ; Giugliani, Roberto (Instituto Nacional de Genética Médica Populacional (Porto Alegre, Brasil)) ; Skuban, Nina (Amicus Therapeutics, Inc., Cranbury, NJ, USA) ; Krusinska, Eva (Amicus Therapeutics, Inc., Cranbury, NJ, USA) ; Feldt-Rasmussen, Ulla (Copenhagen University Hospital Rigshospitalet) ; Schiffmann, Raphael (Institute of Metabolic Disease, Baylor Scott & White Research Institute, Dallas, TX, USA) ; Nicholls, Kathy (Royal Melbourne Hospital (Melbourne, Austràlia)) ; Universitat Autònoma de Barcelona
The effect of migalastat on long-term renal outcomes in enzyme replacement therapy (ERT)-naive and ERT-experienced patients with Fabry disease is not well defined. An integrated posthoc analysis of the phase 3 clinical trials and open-label extension studies was conducted to evaluate long-term changes in renal function in patients with Fabry disease and amenable GLA variants who were treated with migalastat for ≥2 years during these studies. [...]
2021 - 10.1016/j.ymgmr.2021.100786
Molecular Genetics and Metabolism Reports, Vol. 28 (august 2021)  
5.
13 p, 3.0 MB Compliance with good manufacturing practice in the assessment of immunomodulation potential of clinical grade multipotent mesenchymal stromal Cells Derived from Wharton's Jelly / Grau-Vorster, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodríguez, Luciano (Banc de Sang i Teixits) ; del Mazo-Barbara, Anna (Banc de Sang i Teixits) ; Mirabel, Clémentine (Banc de Sang i Teixits) ; Blanco, Margarita (Banc de Sang i Teixits) ; Codinach, Margarita (Banc de Sang i Teixits) ; G. Gómez, Susana (Banc de Sang i Teixits) ; Querol, Sergi (Banc de Sang i Teixits) ; García López, Joan (Banc de Sang i Teixits) ; Vives Armengol, Joaquim (Banc de Sang i Teixits)
The selection of assays suitable for testing the potency of clinical grade multipotent mesenchymal stromal cell (MSC)-based products and its interpretation is a challenge for both developers and regulators. [...]
2019 - 10.3390/cells8050484
Cells, Vol. 8 (2019) , p. 1-13  
6.
28 p, 168.1 KB Migración de retorno en España : salidas de inmigrantes y programas de retorno en un contexto de crisis / Parella Rubio, Sònia (Universitat Autònoma de Barcelona. Grup d'Estudis d'Immigració i Minories Ètniques) ; Petroff, Alisa (Universitat Autònoma de Barcelona. Grup d'Estudis d'Immigració i Minories Ètniques)
El texto parte de un estado de la cuestión en cuanto al cálculo estimado de las salidas de inmigrantes en los últimos cinco años (2007-2012), como reflejo del cambio de las dinámicas que habían caracterizado el modelo migratorio español de los últimos diez años. [...]
This article takes as its starting point the situation with regard to the estimate for immigrant departures in the past five years (2007-2012) as a reflection of the changing dynamics that have characterised the Spanish migration model over the last decade. [...]

2014
Anuario CIDOB de la Inmigración, Núm. Inmigración y Emigración: mitos y realidades (2014) , p. 61-88  
7.
21 p, 227.0 KB De las palabras a los hechos : un proyecto para promover la participación femenina en el deporte universitario. El caso de la Universitat Autònoma de Barcelona / Prat Grau, Maria (Universitat Autònoma de Barcelona) ; Soler Prat, Susanna (Institut Nacional d'Educació Física de Catalunya) ; Carbonero Sánchez, Laura (Universitat Autònoma de Barcelona)
En consonancia con la Declaración de Brighton (Consejo Británico del Deporte, 1994), los gobiernos español y catalán se han comprometido firmemente con las políticas de igualdad en el deporte. Lavoluntad política para resolver las situaciones de desigualdad en el deporte es evidente, pero ¿cómo podemos transformar las palabras en acciones? ¿Cómo se pueden poner en práctica las políticas de igualdad? ¿Cómo reaccionan los organismos deportivos ante estas propuestas? ¿Qué consecuencias y resistencias pueden generar? Para responder estas preguntas, nuestro equipo de investigación y el Servei d'Activitat Física(SAF) de la Universitat Autònoma de Barcelona (UAB), han estado trabajando juntos desde el curso 2006-2007 en el diseño, implementación y evaluación de un proyecto para promover la participación femenina en el SAF. [...]
In line with the Brighton Declaration (British Sports Council, 1994), Spanish and Catalan governments have clearly committed to policies for equality in sport. The political desire to resolve situations of inequality in sport is evident, but how can words be transformed into actions? How can these policies be put into practice? How do sports bodies react to these proposals? What effect will they have? What resistances may arise? To study these questions, the research team and the Servei d'Activitat Física (SAF) at the Universitat Autònoma de Barcelona (UAB), have been working together since 2006-2007 on the design, implementation and evaluation of a project to promote female participation in the SAF. [...]

2012
Ágora para la educación física y el deporte, Núm. 14 (3) (2012), p. 283-302  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.